Marina Moraitou et al.
Molecular genetics and metabolism, 104(1-2), 149-152 (2011-07-13)
An increasing number of clinical, neuropathological and experimental evidence linking Gaucher disease and a spectrum of synucleinopathies, including Parkinson's disease (PD) has emerged over the last decade. In particular, several studies, despite individual differences, have shown that mutations in the